Loading...
Images of Mahrukh Syeda
(0 from 0 )News
Circulating Tumor DNA Provides Prognostic Clues in ...
www.precisiononcologynews.com
· "Although this gene-based test focuses on tumors with BRAF-V600 mutations, we believe it will be similarly useful for melanomas that have other mutations, such as defects in the NRAS and TERT genes, which are also commonly mutated in this disease," first author Mahrukh Syeda, an assistant research assistant at NYU Langone, said in a statement, adding that the …
Gene-Based Blood Test for Melanoma Spread Evaluates ...
www.clinicallab.com
· "Although this gene-based test focuses on tumors with BRAFV600 mutations, we believe it will be similarly useful for melanomas that have other mutations, such as defects in the NRAS and TERT genes, which are also commonly mutated in this disease," says study lead author Mahrukh Syeda, MS. "Ultimately, we'd like to see this test used routinely in the clinic to …
Gene-based blood test may predict treatment success in ...
www.azolifesciences.com
· Mahrukh Syeda, MS, Study Lead Author and Research Scientist, Department of Dermatology, NYU Langone Health. She cautions that the blood test is not yet FDA-approved, but notes that the evidence of its accuracy and value supports future applications for approval to make it available for clinical use.
sorted by relevance / date